Crossref
MEETING REPORT: Antisense Technology—Commercialization of New Biotherapeutics
Antisense Research and Development · 1991
DOI: 10.1089/ard.1991.1.195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antisense Research and Development, 1991. Verfasst von B J Conway und 1 weiteren Autor:innen. Beteiligte Einrichtung: Synthecell Corporation, Rockville, MD 20850. Hauptthemen laut MEDLINE: Antisense Elements (Genetics), Biotechnology. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Antisense Elements (Genetics)BiotechnologyDrug DesignHumans
Substanzen
Antisense Elements (Genetics)
Autor:innen und Institutionen
- Synthecell Corporation, Rockville, MD 20850.
Zitieren
APA
Conway, B. J., & Chrisey, L. A. (1991). MEETING REPORT: Antisense Technology—Commercialization of New Biotherapeutics. Antisense Research and Development. https://doi.org/10.1089/ard.1991.1.195
Vancouver
Conway BJ, Chrisey LA. MEETING REPORT: Antisense Technology—Commercialization of New Biotherapeutics. Antisense Research and Development. 1991. doi:10.1089/ard.1991.1.195
BibTeX
@article{Conway1991,
author = {Conway, B J and Chrisey, L A},
title = {MEETING REPORT: Antisense Technology—Commercialization of New Biotherapeutics},
journal = {Antisense Research and Development},
year = {1991},
doi = {10.1089/ard.1991.1.195}
}
EUVIMED